Exenatide(Byetta) generic is a incretin mimetic, prescribed for type 2 diabetes with diet and exercise, either alone or with other medications. For patients with chronic kidney disease who are at elevated risk for CV events, a glucagon-like peptide 1 receptor agonist may lower risk for albuminuria progression and/or CV events, according to new (2019)recommendations of The American Diabetes Association It works by stimulating the pancreas to secrete insulin in hyperglycemic condition.
More Info about Exenatide